XWEL · XWELL, Inc.
The latest filing states the doubt was alleviated.
“While the Company has suffered recurring losses and negative cash flows from operations, management evaluated whether substantial doubt existed about the Company’s ability to continue as a going concern within one year after the date these unaudited condensed consolidated financial statements are issued. ... Based on its current cash position and expected operating cash flows, the Company believes it has sufficient liquidity to fund its operations and meet its obligations for at least the next twelve months.”View the 10-Q filed Aug 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-02-27 | Wizenberg Gaelle Sandra |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 100,000 restricted stock units ("RSUs"), which such RSUs shall vest on the thirtieth (30th) day following the date of grant, provided that the reporting person remains employed by or is providing services to the Issuer. The RSUs were granted subject to the closing of the transaction contemplated by that certain securities purchase agreement, dated as of February 24, 2026, by and between the Company and the purchaser signatory thereto, which occurred on February 27, 2026. |
Common Stock
|
100,000 |
| 2026-02-27 | Lebowitz Michael |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 100,000 restricted stock units ("RSUs"), which such RSUs shall vest on the thirtieth (30th) day following the date of grant, provided that the reporting person remains employed by or is providing services to the Issuer. The RSUs were granted subject to the closing of the transaction contemplated by that certain securities purchase agreement, dated as of February 24, 2026, by and between the Company and the purchaser signatory thereto, which occurred on February 27, 2026. |
Common Stock
|
100,000 |
| 2026-02-27 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 100,000 restricted stock units ("RSUs"), which such RSUs shall vest on the thirtieth (30th) day following the date of grant, provided that the reporting person remains employed by or is providing services to the Issuer. The RSUs were granted subject to the closing of the transaction contemplated by that certain securities purchase agreement, dated as of February 24, 2026, by and between the Company and the purchaser signatory thereto, which occurred on February 27, 2026. |
Common Stock
|
100,000 |
| 2026-02-27 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 100,000 restricted stock units ("RSUs"), which such RSUs shall vest on the thirtieth (30th) day following the date of grant, provided that the reporting person remains employed by or is providing services to the Issuer. The RSUs were granted subject to the closing of the transaction contemplated by that certain securities purchase agreement, dated as of February 24, 2026, by and between the Company and the purchaser signatory thereto, which occurred on February 27, 2026. |
Common Stock
|
100,000 |
| 2026-02-27 | Ernst Ezra |
President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 100,000 restricted stock units ("RSUs"), which such RSUs shall vest on the thirtieth (30th) day following the date of grant, provided that the reporting person remains employed by or is providing services to the Issuer. The RSUs were granted subject to the closing of the transaction contemplated by that certain securities purchase agreement, dated as of February 24, 2026, by and between the Company and the purchaser signatory thereto, which occurred on February 27, 2026. |
Common Stock
|
100,000 |
| 2025-08-01 | Ernst Ezra |
President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 70,000 restricted stock units ("RSUs") which such RSUs shall vest in four substantially equal installments of the quarterly anniversaries of the grant date, provided that the reporting person remains employed by or is providing services to the Company. |
Common Stock
|
70,000 |
| 2025-06-02 | Wizenberg Gaelle Sandra |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 (Direct)
The reporting person received fully vested restricted stock units, in consideration of the reporting person's Board fees decrease effective in the fourth quarter of 2024. |
Common Stock, par value $0.01
|
89,198 |
| 2025-06-02 | Lebowitz Michael |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 107,724 shares of Common Stock with such stock options vesting in four substantially equal installments on the quarterly anniversaries of the grant date, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
107,724 |
| 2025-06-02 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 117,886 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
117,886 |
| 2025-06-02 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 220,528 shares of Common Stock with such stock options vesting in four substantially equal installments on the quarterly anniversaries of the grant date, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
220,528 |
| 2025-06-02 | Wizenberg Gaelle Sandra |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 97,900 shares of Common Stock with such stock options vesting in four substantially equal installments on the quarterly anniversaries of the grant date, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
97,900 |
| 2025-06-02 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 (Direct)
The reporting person received fully vested restricted stock units, in consideration of the reporting person's Board fees decrease effective in the fourth quarter of 2024. |
Common Stock, par value $0.01
|
200,926 |
| 2025-06-02 | Lebowitz Michael |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
The reporting person received fully vested restricted stock units, in consideration of the reporting person's Board fees decrease effective in the fourth quarter of 2024. |
Common Stock, par value $0.01 per share
|
98,148 |
| 2025-06-02 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 (Direct)
The reporting person received fully vested restricted stock units, in consideration of the reporting person's Board fees decrease effective in the fourth quarter of 2024. |
Common Stock, par value $0.01
|
107,407 |
| 2025-01-06 | Brown Thomas Ian |
CFO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 37,000 shares of common stock, with such options vesting in four quarterly installments of 25% each on the first, second, third and fourth quarters after the grant date, provided that the reporting person is employed by or providing services to the Company through each applicable vesting date. |
Employee stock option (right to buy)
|
37,000 |
| 2025-01-06 | Brown Thomas Ian |
CFO |
Other↑
|
No Securities Owned
|
0 |
| 2024-11-15 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 30,825 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
30,825 |
| 2024-11-15 | Lebowitz Michael |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 22,019 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
22,019 |
| 2024-11-15 | Wizenberg Gaelle Sandra |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 22,019 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
22,019 |
| 2024-11-15 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents stock options to purchase up to 44,037 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date. |
Employee stock option (right to buy)
|
44,037 |
| 2024-09-11 | Wizenberg Gaelle Sandra |
Director |
Buy↑
|
Common Stock
|
1,201 |
| 2024-09-04 | Ernst Ezra |
President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 30,000 shares of restricted common stock, par value $0.01 per share (the "Common Stock") of XWELL, Inc. (the "Company") issued to the reporting person in connection with the reporting person's employment agreement with the Company, effective as of September 4, 2024. One-third of the shares shall vest on each of the first, second and third anniversaries of September 4, 2024, provided that the reporting person remains employed by or is providing services to the Company. |
Common Stock
|
30,000 |
| 2024-09-04 | Ernst Ezra |
President and CEO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Represents 30,000 shares of Common Stock with such options vesting (a) 25% on September 4, 2024, (b) 18.75% on December 31, 2024, (c) 18.75% on March 31, 2025, (d) 18.75% on June 30, 2025, and (e) 18.75% on September 30, 2025, provided that the reporting person is employed by or providing services to the Company through each applicable vesting date. |
Employee stock option (right to buy)
|
30,000 |
| 2024-05-07 | Wizenberg Gaelle Sandra |
Director |
Buy↑
|
Common Stock
|
199 |
| 2024-04-26 | Wizenberg Gaelle Sandra |
Director |
Buy↑
|
Common Stock
|
100 |
| 2024-02-05 | Scrabis Suzanne A. |
Chief Financial Officer |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
10,000 Non-Qualified Stock Options, all of which shall vest on May 5, 2024, three months after the grant date, subject to Ms. Scrabis' continuous service with the Company through such date. |
Employee stock option (right to buy)
|
10,000 |
| 2024-02-05 | Ernst Ezra |
President and CEO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
10,000 Non-Qualified Stock Options, all of which shall vest on May 5, 2024, three months after the grant date, subject to Mr. Ernst's continuous service with the Company through such date. |
Employee stock option (right to buy)
|
10,000 |
| 2024-02-05 | Milford Scott R |
President & CEO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
10,000 Non-Qualified Stock Options, all of which shall vest on May 5, 2024, three months after the grant date, subject to Mr. Milford's continuous service with the Company through such date. |
Employee stock option (right to buy)
|
10,000 |
| 2024-01-08 | Scrabis Suzanne A. |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
On the Transaction Date, the Reporting Person elected to satisfy tax withholding liability incurred upon the vesting of Restricted Stock Units on December 31, 2023 by surrendering some of the shares that vested on such date. |
Common Stock
|
432 |
| 2024-01-01 | Wizenberg Gaelle Sandra |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2023-10-31 | Scrabis Suzanne A. |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
On the Transaction Date, the Reporting Person elected to satisfy tax withholding liability incurred upon the vesting of Restricted Stock Units on September 30, 2023 by surrendering some of the shares that vested on such date. Effective September 28, 2023, the issuer effected a one-for-twenty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. |
Common Stock
|
432 |
| 2023-07-10 | Scrabis Suzanne A. |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2023-07-10 | Scrabis Suzanne A. |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
100,000 Restricted Stock Units ("RSUs") to vest in four quarterly installments of 25.0%, such that the 25.0% of such RSUs will vest on the first, second, third and fourth quarters after the Grant Date (i.e., 9/30/23, 12/31/23, 3/31/24 and 6/30/24), subject to Ms. Scrabis' continuous service with the Company through such dates. |
Common Stock
|
100,000 |
| 2023-07-10 | Scrabis Suzanne A. |
Chief Financial Officer |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
75,000 Non-Qualified Stock Options (the "Options") which shall vest in four quarterly installments of 25.0%, such that the 25.0% of such Options will vest on the first, second, third and fourth quarters after the Grant Date (i.e., 9/30/23, 12/31/23, 3/31/24 and 6/30/24), subject to Ms. Scrabis' continuous service with the Company through such dates. |
Employee stock option (right to buy)
|
75,000 |
| 2023-06-30 | Haynes Omar |
Interim CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects shares of common stock surrendered to satisfy tax withholding obligations in connection with vesting of restricted stock units. |
Common Stock
|
5,963 |
| 2023-06-15 | Haynes Omar |
Interim CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of 100,000 restricted stock units under the XWELL, Inc. 2020 Equity Incentive Plan, which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, commencing on September 30, 2023, such that the options will be fully vested as of June 30, 2024, subject to the Reporting Person's continuous service through such dates. |
Common Stock
|
100,000 |
| 2023-05-30 | WEINSTEIN ROBERT |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.2466 to $0.2480, inclusive. The reporting person undertakes to provide to XWELL, Inc., any security holder of XWELL, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
25,000 |
| 2023-05-26 | WEINSTEIN ROBERT |
Director |
Buy↑
|
Common Stock
|
25,000 |
| 2023-03-31 | Haynes Omar |
Interim CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction was omitted from the reporting person's Form 4 filed on June 16, 2023. The number of shares of common stock reflected in such Form 4 should be deemed adjusted accordingly. Reflects shares of common stock surrendered to satisfy tax withholding obligations in connection with vesting of restricted stock units. |
Common Stock
|
7,412 |
| 2023-01-05 | WEINSTEIN ROBERT |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This grant is pursuant to the directors compensation plan. The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023. |
Stock Option (right to buy)
|
300,000 |
| 2023-01-05 | Milford Scott R |
President & CEO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Option vests in four equal annual increments over each of the first four anniversaries of the date of the grant. |
Employee stock option (right to buy)
|
150,000 |
| 2023-01-05 | Haynes Omar |
Interim CFO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Option vests in four equal annual increments over each of the first four anniversaries of the date of the grant. |
Employee stock option (right to buy)
|
100,000 |
| 2023-01-05 | Stout Donald E. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This grant is pursuant to the directors compensation plan. The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023. |
Stock Option (right to buy)
|
300,000 |
| 2023-01-05 | Bernstein Bruce |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This grant is pursuant to the directors compensation plan. The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023. |
Stock Option (right to buy)
|
600,000 |
| 2023-01-05 | Lebowitz Michael |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This grant is pursuant to the directors compensation plan. The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023. |
Stock Option (right to buy)
|
300,000 |
| 2023-01-05 | Ernst Ezra |
President and CEO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
Option vests in four equal annual increments over each of the first four anniversaries of the date of the grant. |
Employee stock option (right to buy)
|
100,000 |
| 2022-12-31 | Haynes Omar |
Interim CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction was omitted from the reporting person's Form 4 filed on June 16, 2023. The number of shares of common stock reflected in such Form 4 should be deemed adjusted accordingly. Reflects shares of common stock surrendered to satisfy tax withholding obligations in connection with vesting of restricted stock units. |
Common Stock
|
9,083 |
| 2022-12-06 | Milford Scott R |
President & CEO |
Buy↑
|
Common Stock
|
22,950 |
| 2022-12-05 | Milford Scott R |
President & CEO |
Buy↑
|
Common Stock
|
5,800 |
| 2022-12-01 | Bernstein Bruce |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4201 to $0.4299. The Reporting Person undertakes to provide XWELL, Inc., any security holder of XWELL, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
Common Stock
|
33,890 |